$1.02 Billion in Sales Expected for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) This Quarter

Wall Street analysts forecast that DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) will announce sales of $1.02 billion for the current quarter, according to Zacks. Eight analysts have provided estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $984.00 million to $1.04 billion. DENTSPLY SIRONA posted sales of $1.07 billion in the same quarter last year, which would indicate a negative year over year growth rate of 4.7%. The firm is scheduled to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that DENTSPLY SIRONA will report full-year sales of $4.14 billion for the current fiscal year, with estimates ranging from $4.13 billion to $4.15 billion. For the next financial year, analysts expect that the firm will post sales of $4.29 billion, with estimates ranging from $4.25 billion to $4.35 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last announced its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $9.67 billion during the quarter, compared to analyst estimates of $982.05 million. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The firm’s revenue for the quarter was up 841.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.72 earnings per share.

Several brokerages have weighed in on XRAY. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday, May 18th. The Goldman Sachs Group decreased their price target on shares of DENTSPLY SIRONA from $59.00 to $47.00 and set a “neutral” rating on the stock in a research note on Thursday, April 21st. Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $62.00 to $52.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 20th. William Blair cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 19th. Finally, Credit Suisse Group reduced their price objective on shares of DENTSPLY SIRONA from $68.00 to $67.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 1st. Six research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $52.89.

NASDAQ:XRAY opened at $37.75 on Monday. DENTSPLY SIRONA has a 12-month low of $35.00 and a 12-month high of $68.82. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $8.13 billion, a PE ratio of 22.34 and a beta of 0.94. The firm has a 50-day moving average price of $44.51 and a 200 day moving average price of $50.43.

The company also recently announced a quarterly dividend, which was paid on Friday, April 8th. Shareholders of record on Friday, March 25th were issued a $0.125 dividend. The ex-dividend date was Thursday, March 24th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 1.32%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 29.59%.

In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,900 shares of the stock in a transaction on Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total value of $273,999.00. Following the sale, the director now directly owns 35,155 shares in the company, valued at $1,396,005.05. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.76% of the company’s stock.

Several large investors have recently modified their holdings of XRAY. NuWave Investment Management LLC raised its holdings in shares of DENTSPLY SIRONA by 172.8% during the fourth quarter. NuWave Investment Management LLC now owns 502 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 318 shares during the period. SOA Wealth Advisors LLC. grew its position in shares of DENTSPLY SIRONA by 26,666.7% in the 1st quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock valued at $39,000 after acquiring an additional 800 shares during the period. Parkside Financial Bank & Trust grew its position in shares of DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 568 shares during the period. Dark Forest Capital Management LP bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $50,000. Finally, National Bank of Canada FI bought a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $55,000. Institutional investors and hedge funds own 94.79% of the company’s stock.

DENTSPLY SIRONA Company Profile (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Read More

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.